Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.92% to 6,067.70 and the Dow Jones Industrial Average DJIA rising 0.31% to 44,850.35.

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevance Health Inc.'s stock rose 2% Thursday ... The stock has fallen 16% in the last 12 months, while the S&P 500 SPX has gained 25%. Chip stocks and other AI-related plays take a hit as ...

U.S. stocks rose to a record as Wall Street regained some of the momentum that catapulted it to 57 all-time highs last year.

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other managed care insurers have largely bounced back.

In general, value stocks tend to be those of mature companies that are growing relatively slowly and that pay dividends. Growth stocks are those of rapidly growing companies that tend to trade at relatively high valuations and may or may not pay dividends as they emphasize expanding their businesses.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Best-in-class option for large-cap investors. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a ...